![Peter Greaney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Peter Greaney
Anciens postes connus de Peter Greaney
Sociétés | Poste | Début | Fin |
---|---|---|---|
CELGENE | Directeur des opérations | 01/01/2006 | 01/01/2018 |
ADC THERAPEUTICS SA | Corporate Officer/Principal | 01/09/2018 | - |
Formation de Peter Greaney
University of East Anglia | Undergraduate Degree |
The University of Nottingham | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 3 |
Suisse | 2 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
Entreprise privées | 1 |
---|---|
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bourse
- Insiders
- Peter Greaney
- Expérience